Composition and method for delivery of biologically-active factors


Ontology type: sgo:Patent     


Patent Info

DATE

2001-08-14T00:00

AUTHORS

Lawrence Tamarkin , Guilio F. Paciotti

ABSTRACT

In accordance with the present invention, a composition and method is provided that allows for the administration of a biologically-active factors to a human or animal. The present invention can be used to treat a disease with a biologically-active factor or combination of biologically-active factors, or can be used to safely vaccinate a human or animal against a biologically-active factor. It can also be used as a method for the delivery of biologically-active factors for the treatment of disease. Additionally, the present invention also includes a method of targeted drug delivery for the treatment of disease through the administration of custom complexes containing of one or more biologically active factors bound to a colloidal metal where at least one of the biologically-active factors is capable of binding a high affinity receptor on a cell surface. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2837", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Lawrence Tamarkin", 
        "type": "Person"
      }, 
      {
        "name": "Guilio F. Paciotti", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf02536550", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004951825", 
          "https://doi.org/10.1007/bf02536550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-8993(91)90510-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008027838"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-8993(91)90510-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008027838"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19910401)67:7<1862::aid-cncr2820670708>3.0.co;2-r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011004738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02536542", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023062868", 
          "https://doi.org/10.1007/bf02536542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/40.5.1573251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027563932"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/40.5.1573251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027563932"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7883/yoken1952.44.75", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041681947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-5699(89)90085-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043142236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-5699(89)90085-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043142236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/37.2.2911004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053830886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/37.2.2911004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053830886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jlb.48.4.316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078321366"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-08-14T00:00", 
    "description": "

In accordance with the present invention, a composition and method is provided that allows for the administration of a biologically-active factors to a human or animal. The present invention can be used to treat a disease with a biologically-active factor or combination of biologically-active factors, or can be used to safely vaccinate a human or animal against a biologically-active factor. It can also be used as a method for the delivery of biologically-active factors for the treatment of disease. Additionally, the present invention also includes a method of targeted drug delivery for the treatment of disease through the administration of custom complexes containing of one or more biologically active factors bound to a colloidal metal where at least one of the biologically-active factors is capable of binding a high affinity receptor on a cell surface.

", "id": "sg:patent.US-6274552-B1", "keywords": [ "composition", "method", "delivery", "active factor", "accordance", "invention", "Organization and Administration", "animal", "disease", "targeted drug delivery", "complex", "metal", "binding", "high affinity receptor", "cell surface" ], "name": "Composition and method for delivery of biologically-active factors", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.470309.9", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-6274552-B1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:27", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_03093.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-6274552-B1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-6274552-B1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-6274552-B1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-6274552-B1'


 

This table displays all metadata directly associated to this object as RDF triples.

70 TRIPLES      15 PREDICATES      38 URIs      23 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-6274552-B1 schema:about anzsrc-for:2837
2 schema:author N6180fb36b45c4aa79f3e1ddebb03a31d
3 schema:citation sg:pub.10.1007/bf02536542
4 sg:pub.10.1007/bf02536550
5 https://doi.org/10.1002/1097-0142(19910401)67:7<1862::aid-cncr2820670708>3.0.co;2-r
6 https://doi.org/10.1002/jlb.48.4.316
7 https://doi.org/10.1016/0006-8993(91)90510-3
8 https://doi.org/10.1016/0167-5699(89)90085-6
9 https://doi.org/10.1177/37.2.2911004
10 https://doi.org/10.1177/40.5.1573251
11 https://doi.org/10.7883/yoken1952.44.75
12 schema:datePublished 2001-08-14T00:00
13 schema:description <p>In accordance with the present invention, a composition and method is provided that allows for the administration of a biologically-active factors to a human or animal. The present invention can be used to treat a disease with a biologically-active factor or combination of biologically-active factors, or can be used to safely vaccinate a human or animal against a biologically-active factor. It can also be used as a method for the delivery of biologically-active factors for the treatment of disease. Additionally, the present invention also includes a method of targeted drug delivery for the treatment of disease through the administration of custom complexes containing of one or more biologically active factors bound to a colloidal metal where at least one of the biologically-active factors is capable of binding a high affinity receptor on a cell surface.</p>
14 schema:keywords Organization and Administration
15 accordance
16 active factor
17 animal
18 binding
19 cell surface
20 complex
21 composition
22 delivery
23 disease
24 high affinity receptor
25 invention
26 metal
27 method
28 targeted drug delivery
29 schema:name Composition and method for delivery of biologically-active factors
30 schema:recipient https://www.grid.ac/institutes/grid.470309.9
31 schema:sameAs https://app.dimensions.ai/details/patent/US-6274552-B1
32 schema:sdDatePublished 2019-04-18T10:27
33 schema:sdLicense https://scigraph.springernature.com/explorer/license/
34 schema:sdPublisher N638927bdebf345c090d9662bbb494c6f
35 sgo:license sg:explorer/license/
36 sgo:sdDataset patents
37 rdf:type sgo:Patent
38 N163e6ebb7b4d4c2c959853252e28433c rdf:first Na28110d7562a4d3a862b6b839c92bc6a
39 rdf:rest rdf:nil
40 N6180fb36b45c4aa79f3e1ddebb03a31d rdf:first Nb579d80435db40bbba6cb4a16f236b80
41 rdf:rest N163e6ebb7b4d4c2c959853252e28433c
42 N638927bdebf345c090d9662bbb494c6f schema:name Springer Nature - SN SciGraph project
43 rdf:type schema:Organization
44 Na28110d7562a4d3a862b6b839c92bc6a schema:name Guilio F. Paciotti
45 rdf:type schema:Person
46 Nb579d80435db40bbba6cb4a16f236b80 schema:name Lawrence Tamarkin
47 rdf:type schema:Person
48 anzsrc-for:2837 schema:inDefinedTermSet anzsrc-for:
49 rdf:type schema:DefinedTerm
50 sg:pub.10.1007/bf02536542 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023062868
51 https://doi.org/10.1007/bf02536542
52 rdf:type schema:CreativeWork
53 sg:pub.10.1007/bf02536550 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004951825
54 https://doi.org/10.1007/bf02536550
55 rdf:type schema:CreativeWork
56 https://doi.org/10.1002/1097-0142(19910401)67:7<1862::aid-cncr2820670708>3.0.co;2-r schema:sameAs https://app.dimensions.ai/details/publication/pub.1011004738
57 rdf:type schema:CreativeWork
58 https://doi.org/10.1002/jlb.48.4.316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078321366
59 rdf:type schema:CreativeWork
60 https://doi.org/10.1016/0006-8993(91)90510-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008027838
61 rdf:type schema:CreativeWork
62 https://doi.org/10.1016/0167-5699(89)90085-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043142236
63 rdf:type schema:CreativeWork
64 https://doi.org/10.1177/37.2.2911004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053830886
65 rdf:type schema:CreativeWork
66 https://doi.org/10.1177/40.5.1573251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027563932
67 rdf:type schema:CreativeWork
68 https://doi.org/10.7883/yoken1952.44.75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041681947
69 rdf:type schema:CreativeWork
70 https://www.grid.ac/institutes/grid.470309.9 schema:Organization
 




Preview window. Press ESC to close (or click here)


...